Amlexanox
-
Amlexanox
structure -
-
CAS No:
68302-57-8
-
Formula:
C16H14N2O4
-
Chemical Name:
Amlexanox
-
Synonyms:
5H-[1]Benzopyrano[2,3-b]pyridine-3-carboxylic acid,2-amino-7-(1-methylethyl)-5-oxo-;2-Amino-7-(1-methylethyl)-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid;AA 673;Amoxanox;Amlexanox;Elics;CHX 3673;Solfa;Aphtheal;Aphthasol;2-Amino-5-oxo-7-propan-2-ylchromeno[2,3-b]pyridine-3-carboxylic acid;2-Amino-7-isopropyl-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylicacid
- Categories:
-
CAS No:
Description
AmLexanox is a specific inhibitor of IKKε and TBK1, and inhibits the IKKε and TBK1 activity determined by MBP phosphorylation with an IC50 of approximately 1-2 μM.
Solid
Amlexanox is a pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position. It has a role as an anti-allergic agent, an anti-ulcer drug and a non-steroidal anti-inflammatory drug. It is a pyridochromene and a monocarboxylic acid.|Amlexanox is an antiallergic drug, clinically effective for atopic diseases, especially allergic asthma and rhinitis. Amlexanox as a topical paste is a well tolerated treatment of recurrent aphthous ulcers. Recurrent aphthous ulcer (RAU) is the most prevalent oral mucosal disease in humans, estimated to affect between 5% and 50% of the general population.|The physiologic effect of amlexanox is by means of Decreased Histamine Release.|Amlexanox is an anti-aphthous ulcer drug. Amlexanox inhibits the synthesis and release of inflammatory mediators, including leukotrienes and histamine, from mast cells, neutrophils, and mononuclear cells. Amlexanox also acts as a leukotriene D4 antagonist and a phosphodiesterase inhibitor. Amlexanox decreases the time ulcers take to heal as well as the pain associated with the ulcers.
Amlexanox Basic Attributes
298.29300
298.29
BRL1C2459K
DTXSID2022595
C47395
A - Alimentary tract and metabolism|R - Respiratory system
2934999090
Characteristics
106.42000
3.1
white crystalline solid
1.408 g/cm3
>300 °C
570ºC at 760 mmHg
298.5ºC
1.668
1.46e-01 g/L
Store in original container in a cool dark place.
Safety Information
NONH for all modes of transport
3
R22; R36/37/38
S26; S36
XZ3012000
Xn; Xi
P301 + P312 + P330
H302
Drug Information
Used as a paste in the mouth to treat aphthous ulcers (canker sores).|FDA Label
Amlexanox is a mucoadhesive oral paste which has been clinically proven to abort the onset, accelerate healing and resolve the pain of aphthous ulcers (canker sores). It decreases the time ulcers take to heal. Because amlexanox decreases the healing time, it also decreases the pain you feel. Recent studies have also shown that the majority of ulcers can be prevented by application of the paste during the prodromal (pre-ulcerative) phase of the disease. Recurrent Aphthous Ulcers (RAU) also known as Recurrent Aphthous Stomatitis (RAS) is recognized as the most common oral mucosal disease known to man. Estimates suggest that 20% - 25% of the general population suffer at least one incidence of aphthous ulcers each year. Amlexanox is also being investigated for its anti-allergenic and anti-inflammatory properties.
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
No significant absorption directly through the active ulcer. Most of the systemic absorption is via the gastrointestinal tract.
Metabolized to hydroxylated and conjugated metabolites.
Elimination half-life is 3.5 ± 1.1 hours.
As a benzopyrano-bipyridine carboxylic acid derivative, amlexanox has anti-inflammatory and antiallergic properties. It inhibits chemical mediatory release of the slow-reacting substance of anaphylaxis (SRS-A) and may have antagonistic effects on interleukin-3. When cells are under stress, they release an inactive form of human fibroblast growth factor 1 (FGF-1), a potent mitogen (entity that causes mitosis). Amlexanox binds to FGF1, increasing its conformational stability, sterically blocking Cu(2+) induced oxidation which normally leads to activation of FGF-1.
2-amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3b)pyridine-3-carboxylic acid
Amlexanox Use and Manufacturing
Inhibits release of allergic mediators from mast cells. Antiallergic; antiasthmaticIt has histamine free reaction inhibitory effect, leukotriene production inhibitory effect and anti-leukotriene effect, resulting in anti-asthma effects. For the treatment of bronchial asthma and allergic rhinitis. Used to treat oral ulcers Antihistamines have a high degree of selectivity for peripheral nerve H1 receptors, a strong effect and a long time. Used for allergic arthritis and allergic rhinitis. National Class II anti-allergic new drug, used to relieve nasal and non-nasal symptoms of seasonal allergic rhinitis and relieve chronic urticaria
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:298.29
XLogP3:3.1
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:2
Exact Mass:298.09535693
Monoisotopic Mass:298.09535693
Topological Polar Surface Area:103
Heavy Atom Count:22
Complexity:467
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
The mechanism of action is mainly to inhibit lipopolysaccharide synthase, inhibit the production of leukotrienes and anti-leukotrienes, and accelerate the healing of aphthous ulcers through anti-allergic and anti-inflammatory effects.
Registered Holders
-
Shandong Keyuan Pharmaceutical Co., Ltd.
Active
China
-
Sichuan Xuhui Pharmaceutical Co., Ltd.
Active
China
-
CHIA TAI Tianqing Pharmaceutical Group Co., Ltd.
Active
China
Recommended Suppliers of Amlexanox
-
CN
3 YRS
Business licensedDistributor Supplier of (R)-3-hydroxypyrrolidine hydrochloride,(R)-Glycidyl butyrate,fine chemicals,2-dibromo-4,5-difluorobenzene,(S)-(+)-Mandelic acid,3-Bromo-1-propanol,1,1-Bis(hydroxymethyl)cyclopropane,1-Chloroethyl chloroformate,1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride,Diethyl azodicarboxylate,Potassium tert-butoxide,Benzydamine hydrochloride,2-Methylpiperazine,Diisopropyl azodicarboxylate,N-Methylbenzylamine,Hexamethylphosphoramide -
CN
5 YRS
Business licensedTrader Supplier of API,nutrition supplements,plant extract,peptide,HCGInquiryCAS No.: 68302-57-8Grade: Pharmaceutical GradeContent: 99% -
CN
4 YRS
Business licensedTrader Supplier of intermediates ,fine chemical,food additives -
CN
4 YRS
Business licensedTrader Supplier of Semaglutide,Tirzepatide,API,EnzymeInquiryCAS No.: 68302-57-8Grade: Industrial GradeContent: 98.50% -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Herb Extracts,Cosmetic raw materails,API
Learn More Other Chemicals
-
Pseudopurpurin
476-41-5
-
Glycidic acid
503-11-7
-
Olopatadine
113806-05-6
-
(±)-Carbinoxamine Formula
486-16-8
-
(±)-Promethazine Formula
60-87-7
-
(+)-Chlorpheniramine Formula
25523-97-1
-
Dipicrylamine Structure
131-73-7
-
Thenalidine Structure
86-12-4
-
What is Thiazinamium methyl sulfate
58-34-4
-
What is Bromodiphenhydramine
118-23-0